GL1X · GenesisL1 explorer

MolNFT v1 · #95812 · protein

Crystal structures of fabi from F. tularensis in complex with novel inhibitors based on the benzimidazole scaffold

4J1N · Enoyl-[acyl-carrier-protein] reductase [NADH]: “Crystal structures of fabi from F. tularensis in complex with novel inhibitors based on the benzimidazole…”. X-ray diffraction, 2 ligands (NAD, 1JN), 3 pockets (best druggability…

PDB
4J1N
Type
protein
Length
516 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Enoyl-[acyl-carrier-protein] reductase [NADH]
EC
1.3.1.9
UniProt
Q5NGQ3
Ligands
NAD, 1JN
Pockets
3 · best druggability 0.79

Structure

x-ray diffraction · 1 distinct chain · 50% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BEnoyl-[acyl-carrier-protein] reductase [NADH] (EC 1.3.1.9)protein25850% helix, 14% strandQ5NGQ3

Ligands and binding sites

  • NAD · Nicotinamide-adenine-dinucleotide · ligand · 2 copies · chains A, B
  • 1JN · 1-(4-methoxy-3-methylbenzyl)-1,5,6,7-tetrahydroindeno[5,6-d]imidazole · ligand · 2 copies · chains A, B
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15850.790.8548NAD, 1JN
25810.790.8452NAD, 1JN
31860.420.7318empty

Interfaces

1 interface between chains.

  • A–B · 1374 Ų buried · 14 hydrogen bonds · protein-protein

Compared structures

  • 4J1N · Crystal structures of FabI from F. tularensis in complex with novel inhibitors based on… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.